Page last updated: 2024-08-18

4-cymene and Inflammation

4-cymene has been researched along with Inflammation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Ghasemi Gojani, E; Ilnytskyy, Y; Kovalchuk, I; Kovalchuk, O; Li, D1
Alsayrafi, D; Garelnabi, M; Mazhar, Z; Wu, T1
Chen, N; Feng, H; Li, H; Liu, F; Liu, G; Soromou, LW; Wu, Q; Xie, G; Xiong, Y1
Chen, N; Chi, G; Deng, X; Feng, H; Guo, W; Huo, M; Jiang, L; Soromou, LW; Zhong, W1

Other Studies

4 other study(ies) available for 4-cymene and Inflammation

ArticleYear
Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.
    Molecules (Basel, Switzerland), 2022, Sep-16, Volume: 27, Issue:18

    Topics: Anti-Inflammatory Agents; Camphor; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cyclooxygenase 2; Cymenes; Dronabinol; Eucalyptol; Hallucinogens; Humans; Inflammation; Interleukin-6; Plant Extracts; Terpenes; Tumor Necrosis Factor-alpha

2022
p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis.
    Cardiovascular & hematological agents in medicinal chemistry, 2020, Volume: 18, Issue:2

    Topics: Animals; Atherosclerosis; Cymenes; Environmental Pollutants; Gene Expression Regulation; Inflammation; Macrophages; Mice; Oxidative Stress; RAW 264.7 Cells

2020
p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation.
    Molecules (Basel, Switzerland), 2012, Jul-06, Volume: 17, Issue:7

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cell Count; Cymenes; Cytokines; Inflammation; Inflammation Mediators; Lipopolysaccharides; Lung; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Monoterpenes; NF-kappa B; Peroxidase; Protective Agents; Water

2012
p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation.
    Inflammation, 2013, Volume: 36, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cymenes; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; I-kappa B Proteins; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Monoterpenes; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Tumor Necrosis Factor-alpha

2013